Reuters

EWN default image new logo

News Feed

Rand rallies in risk-on trade

Markets latched onto the US Food & Drug Administration’s 'emergency use authorisation' for the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the disease.

WHO: 172 countries engaging with global COVID-19 vaccine plan

WHO director-general Tedros Adhanom Ghebreyesus said the facility was critical to ending the COVID-19 pandemic, and would not only pool risk for countries developing and buying vaccines, but also ensure prices are kept 'as low as possible'.